MEDVi vs Strut Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Strut Health scores higher on our rubric, 6.2/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Strut Health - our pick of these two →or find your match

Strut Health beats MEDVi overall, scoring 6.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Strut Health is from $99/mo. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program. Choose Strut Health for users who prefer a needle-free oral semaglutide option at a reasonable price.

A side-by-side look at MEDVi and Strut Health to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

MEDVi

#46 of 54

5.7/10

MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Higher Rated

Strut Health

#43 of 54

6.2/10

Oral-focused GLP-1 provider offering needle-free semaglutide options for users who prefer pills over injections.

Visit Strut Health

Feature	MEDVi	Strut Health
Why each one	Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication.	Needle-free first: oral compounded semaglutide from $99/mo, one of the lowest oral entry prices anywhere, with oral tirzepatide and auto-refill injectables on the same platform if you switch.
Our Score	5.7/10	6.2/10
Headline Price	$179 first month, then $299/mo	from $99/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want both oral and injectable compounded options in one telehealth program	Users who prefer a needle-free oral semaglutide option at a reasonable price
Watch out for	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication	Compounded only, no brand-name Wegovy or Zepbound. Strut does not publish formulation-specific pharmacokinetic or comparative outcome evidence for its oral tablets, so their absorption and weight-loss results versus approved injections are unknown.
Ranking	#46	#43
Get started	Visit MEDVi	Visit Strut Health

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
−The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Strut Health

Pros

+Specializes in oral compounded semaglutide, the go-to for patients who absolutely won't do injections
+Needle-free oral semaglutide tablets from $99/mo, one of the lowest oral entry prices in the table, with oral tirzepatide ($199/mo) and auto-refill injectables ($149 to $199/mo) if you switch formats
+Clear educational content about oral semaglutide absorption and how to maximize effectiveness
+Simple enrollment: online questionnaire, async provider review, medication shipped to your door

Cons

−Compounded only, no brand-name Wegovy or Zepbound. Strut does not publish formulation-specific pharmacokinetic or comparative outcome evidence for its oral tablets, so their absorption and weight-loss results versus approved injections are unknown.
−Compounded oral semaglutide is not FDA-approved as a finished product or established as bioequivalent to approved oral or injectable semaglutide; do not infer equivalent dosing or results

Our Verdict

Strut Health edges out MEDVi with a score of 6.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Strut Health is from $99/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility.